Johnson & Johnson sales rise 6% and it lifts its 2026 outlook
Published
The drug and device maker reported $25.4 billion in third-quarter sales and expects to top $100 billion for the year.
Source: Johnson & Johnson
This is a plain-language summary. Read the original source for full details.